The European Union's drugs regulator on Thursday recommended approval for Eisai and Biogen's Leqembi in some patients with ...

The European Union's drugs regulator on Thursday said it recommends approval of Eisai and Biogen's Leqembi in patients with ...

Reversing an earlier decision, European regulators recommended that an Alzheimer’s therapy from Eisai and Biogen should be ...

As we count down toward the December readout of Cassava Sciences’ simufilam Phase 3 clinical trial in Alzheimer’s disease, it ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Berislav Zlokovic, MD, PhD, a prominent ...

An anti-Alzheimer's nasal spray that could delay the progress of the disease by years has been developed by scientists at ...

An international collaboration led by RIKEN researchers has discovered how unusual spherical structures form in the brains of ...

During National Family Caregivers Month in November, the Alzheimer’s Association is encouraging dementia caregivers to make their own health an equal priority as they navigate the demands and stresses ...

Researchers discovered that the enzyme TYK2 alters the tau protein, promoting its accumulation in the brain, a process linked ...

University of Washington-led research, published in 2023, discovered microglia in the brains of people with Alzheimer's ...

The onset of symptoms of Alzheimer's disease can occur and worsen faster in people that also have an alcohol use disorder ...

In 2022, The Tulsa Opera partnered with a program called Songs By Heart that works to bring live, interactive, music therapy ...